Saturday, February 27, 2021

Novavax could have a ‘recreation changer’ COVID-19 vaccine on its fingers

The Wall Avenue Journal with the report 

The Novavax vaccine, it says, presents key doable benefits over its opponents:

  • early knowledge counsel the Novavax shot could also be one of many first proven to stem asymptomatic unfold of the coronavirus
  • and in addition probably present longer-lasting safety

Its a 2 shot vaccine. Approval nonetheless seems a few months away.

An attention-grabbing learn however the agency has clearly misplaced first-mover benefit and by the point it will get approval, then into distribution, it would properly be too late? 

The Wall Street Journal with the report 

Please Post Your Comments & Reviews

Your email address will not be published. Required fields are marked *